News
GlobalData on MSN15h
Cognition Therapeutics’ drug shows 129% cognitive decline arrest in mild Alzheimer’sCognition Therapeutics’ therapy showed up to a 129% slowing of cognitive decline in mild Alzheimer’s disease patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback